|
|
|
41
|
6211D
|
MIDAZOLAM 5MG/ML INJ (RTM) (B)
|
MIDAZOLAM
|
MIDAZOLAM
|
10X3ML
|
B
|
36.5
|
3.65
|
AMP
|
0
|
BOX
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
282408
|
BENZODIAZEPINES (SEDATIVES)
|
2024-05-25
|
2026-03-31
|
|
IV
|
0
|
BENZODIAZEPINES (SEDATIVES)
|
2024-04-01
|
|
|
|
41
|
62121
|
DORMICUM 5MG/ML INJ (ROC) MIDAZOLAM (C)
|
MIDAZOLAM
|
DORMICUM
|
5X10ML
|
C
|
51.65
|
10.3296
|
VIAL
|
0
|
BOX
|
ROC
|
ROCHE SERVICIOS S.A.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
282408
|
BENZODIAZEPINES (SEDATIVES)
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
BENZODIAZEPINES (SEDATIVES)
|
|
|
|
|
41
|
6212N
|
MIDAZOLAM 5MG/ML INJ (KWA) (B)
|
MIDAZOLAM
|
MIDAZOLAM
|
10ML VIAL
|
B
|
4.08
|
4.0775
|
VIAL
|
0
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
282408
|
BENZODIAZEPINES (SEDATIVES)
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
BENZODIAZEPINES (SEDATIVES)
|
|
|
|
|
40
|
6212P
|
MIDAZOLAM 5MG/ML INJ (BRA/COL)
|
MIDAZOLAM
|
MIDAZOLAM
|
20X10ML
|
B
|
67.22
|
3.36
|
INJECTION
|
0
|
VIAL
|
BRA
|
B. BRAUN MELSUNGEN AG CARL-BRAUN-STRABE
|
COL
|
COLLINS LTD
|
|
282408
|
BENZODIAZEPINES (SEDATIVES)
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
6212P
|
MIDAZOLAM 5MG/ML INJ (BRA) (B)
|
MIDAZOLAM
|
MIDAZOLAM
|
20X10ML
|
B
|
93.13
|
4.6565
|
VIAL
|
0
|
BOX
|
BRA
|
B. BRAUN MELSUNGEN AG CARL-BRAUN-STRABE
|
COL
|
COLLINS LTD
|
|
282408
|
BENZODIAZEPINES (SEDATIVES)
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
BENZODIAZEPINES (SEDATIVES)
|
|
|
|
|
42
|
6212P
|
MIDAZOLAM 5MG/ML INJ (BRA)
|
MIDAZOLAM
|
MIDAZOLAM
|
20X10ML
|
B
|
215.29
|
10.76
|
VIAL
|
0
|
VIAL
|
BRA
|
B. BRAUN MELSUNGEN AG CARL-BRAUN-STRABE
|
COL
|
AVENTA BARBADOS
|
|
282408
|
BENZODIAZEPINES (SEDATIVES)
|
2026-04-01
|
|
|
IV
|
0
|
BENZODIAZEPINES (SEDATIVES)
|
|
|
|
|
40
|
6251C
|
POTASSIUM PHOSPHATE 3MMOL/ML INJ (LDP/AHI)
|
POTASSIUM PHOSPHATE
|
POTASSIUM PHOSPHATE
|
15ML
|
BQ
|
11.74
|
11.74
|
INJECTION
|
0
|
VIAL
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
4012
|
REPLACEMENT THERAPY
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ELECTROLYTIC, CALORIC, AND WATER BALANCE
|
|
|
|
|
41
|
6251D
|
POTASSIUM PHOSPHATE 3MMOL/ML INJ (KWA) (BQ)
|
POTASSIUM PHOSPHATE
|
POTASSIUM PHOSPHATE
|
15ML VIAL
|
BQ
|
6.93
|
6.9317
|
VIAL
|
0
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
4012
|
REPLACEMENT THERAPY
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
REPLACEMENT THERAPY
|
|
|
|
|
40
|
62614
|
N-MYCIN 5% EYE DR (ARP/AHI) NATAMYCIN
|
NATAMYCIN
|
N-MYCIN
|
5ML
|
BQ
|
20.99
|
20.99
|
EYE DROP
|
0
|
BOTT
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
520416
|
EENT ANTIFUNGALS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
62615
|
NATACIN 5% EYE DR (AKU) NATAMYCIN
|
NATAMYCIN
|
NATACIN
|
5ML
|
BQ
|
5.52
|
5.5182
|
BOTT
|
0
|
BOTT
|
AKU
|
AKUMS DRUGS AND PHARMACEUTICALS
|
PSB
|
PHARMACEUTICAL SOLUTIONS BARBA
|
|
520416
|
EENT ANTIFUNGALS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
0
|
EENT ANTIFUNGALS
|
|
|
|
|
42
|
62615
|
NATACIN 5% EYE DR (AKU) NATAMYCIN
|
NATAMYCIN
|
NATACIN
|
5ML
|
BQ
|
5.44
|
5.44
|
BOTT
|
0
|
VIAL
|
AKU
|
AKUMS DRUGS AND PHARMACEUTICALS
|
PSB
|
PHARMACEUTICAL SOLUTIONS BARBA
|
|
520416
|
EENT ANTIFUNGALS
|
2026-04-01
|
|
|
OPHTHALMIC
|
0
|
EENT ANTIFUNGALS
|
|
|
|
|
40
|
6302AL
|
CISATRACURIUM 2.5MG/ML INJ (OMG/COL)
|
CISATRACURIUM
|
CISATRACURIUM
|
10X10ML
|
BQ
|
232.42
|
23.24
|
INJECTION
|
0
|
VIAL
|
OMG
|
OMEGA
|
COL
|
COLLINS LTD
|
|
122020
|
NEUROMUSCULAR BLOCKING AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
42
|
6302AL
|
CISATRACURIUM 2.5MG/ML INJ (OMG)
|
CISATRACURIUM
|
CISATRACURIUM
|
10X10ML
|
BQ
|
163.10
|
16.31
|
VIAL
|
400
|
VIAL
|
OMG
|
OMEGA
|
COL
|
AVENTA BARBADOS
|
|
122020
|
NEUROMUSCULAR BLOCKING AGENTS
|
2026-04-01
|
|
|
IV
|
0
|
NEUROMUSCULAR BLOCKING AGENTS
|
|
|
|
|
40
|
6302AQ
|
NIMBEX 2MG/ML INJ (ASG/STO) CISATRACURIUM
|
CISATRACURIUM
|
NIMBEX
|
5X5ML
|
BQ
|
114.17
|
22.83
|
INJECTION
|
0
|
VIAL
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
|
122020
|
NEUROMUSCULAR BLOCKING AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
41
|
6302AQ
|
NIMBEX 2MG/ML INJ (ASG) CISATRACURI (BQ)
|
CISATRACURIUM
|
NIMBEX
|
5X5ML
|
BQ
|
114.17
|
22.8339
|
VIAL
|
0
|
BOX
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
|
122020
|
NEUROMUSCULAR BLOCKING AGENTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
NEUROMUSCULAR BLOCKING AGENTS
|
|
|
|
|
42
|
6302AQ
|
NIMBEX 2MG/ML INJ (ASG) CISATRACURI
|
CISATRACURIUM
|
NIMBEX
|
5X5ML
|
BQ
|
130.07
|
26.01
|
VIAL
|
0
|
VIAL
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
|
122020
|
NEUROMUSCULAR BLOCKING AGENTS
|
2026-04-01
|
|
|
IV
|
0
|
NEUROMUSCULAR BLOCKING AGENTS
|
|
|
|
|
41
|
6302AR
|
CISATRACURIUM 2.5MG/ML INJ (LDP) (BQ)
|
CISATRACURIUM
|
CISATRACURIUM
|
10ML
|
BQ
|
19.65
|
19.6535
|
VIAL
|
400
|
VIAL
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
122020
|
NEUROMUSCULAR BLOCKING AGENTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
NEUROMUSCULAR BLOCKING AGENTS
|
|
|
|
|
40
|
63416
|
STAMARIL (AVP/COL) YELLOW FEVER
|
YELLOW FEVER VIRUS
|
STAMARIL
|
1 DS SYRNG
|
B
|
53.82
|
53.82
|
INJECTION
|
0
|
VIAL
|
AVP
|
SANOFI PASTEUR
|
COL
|
COLLINS LTD
|
|
8012
|
VACCINES
|
2022-04-01
|
2024-03-31
|
|
IM
|
0
|
SERUMS, TOXOIDS AND VACCINES
|
|
|
|
|
41
|
63416
|
STAMARIL (AVP) YELLOW FEVER
|
YELLOW FEVER VIRUS
|
STAMARIL
|
1 DS VIAL
|
B
|
53.82
|
53.8228
|
VIAL
|
20
|
VIAL
|
AVP
|
SANOFI PASTEUR
|
COL
|
COLLINS LTD
|
|
8012
|
VACCINES
|
2024-04-01
|
2024-10-21
|
|
IM
|
0
|
VACCINES
|
2024-09-09
|
|
|
|
40
|
64212
|
NEORAL 100MG/ML SOLN (NVS/COL) CYCLOSPORIN
|
CYCLOSPORIN
|
NEORAL
|
50ML
|
BQ
|
475.71
|
475.71
|
SOLUTION
|
0
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTINEOPLASTICS
|
|
